膝骨关节炎——我们距离疾病改善治疗还有多远：重点关注代谢型膝骨关节炎
Knee Osteoarthritis-How Close Are We to Disease-Modifying Treatment: Emphasis on Metabolic Type Knee Osteoarthritis.
作者信息
Lambova Sevdalina Nikolova
机构信息
Department of Propaedeutics of Internal Diseases, Faculty of Medicine, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria.
Department in Rheumatology, MHAT "Sveti Mina", 4002 Plovdiv, Bulgaria.
出版信息
Life (Basel). 2023 Jan 4;13(1):140. doi: 10.3390/life13010140.
Abstract
Osteoarthritis (OA) is a whole-joint disease that affects cartilage, bone, and synovium as well as ligaments, menisci, and muscles [...].
摘要
骨关节炎（OA）是一种全关节疾病，会影响软骨、骨骼、滑膜以及韧带、半月板和肌肉[...]。
相似文献
1
Knee Osteoarthritis-How Close Are We to Disease-Modifying Treatment: Emphasis on Metabolic Type Knee Osteoarthritis.膝骨关节炎——我们距离疾病改善治疗还有多远：重点关注代谢型膝骨关节炎
Life (Basel). 2023 Jan 4;13(1):140. doi: 10.3390/life13010140.
2
From Pathogenesis to Therapy in Knee Osteoarthritis: Bench-to-Bedside.从膝骨关节炎的发病机制到治疗：从基础到临床。
Int J Mol Sci. 2021 Mar 7;22(5):2697. doi: 10.3390/ijms22052697.
3
Cartilage degradation in osteoarthritis: A process of osteochondral remodeling resembles the endochondral ossification in growth plate?骨关节炎中的软骨降解：类似于生长板的软骨内骨化过程的骨软骨重塑？
Med Hypotheses. 2018 Dec;121:183-187. doi: 10.1016/j.mehy.2018.08.023. Epub 2018 Aug 27.
4
The relationship between specific tissue lesions and pain severity in persons with knee osteoarthritis.膝关节骨关节炎患者特定组织损伤与疼痛严重程度之间的关系。
Osteoarthritis Cartilage. 2006 Oct;14(10):1033-40. doi: 10.1016/j.joca.2006.03.015. Epub 2006 May 18.
5
Current perspectives in stem cell therapies for osteoarthritis of the knee.膝关节骨关节炎干细胞治疗的当前观点
Yeungnam Univ J Med. 2020 Jul;37(3):149-158. doi: 10.12701/yujm.2020.00157. Epub 2020 Apr 13.
6
The infrapatellar fat pad should be considered as an active osteoarthritic joint tissue: a narrative review.髌下脂肪垫应被视为活跃的骨关节炎性关节组织：叙述性综述。
Osteoarthritis Cartilage. 2010 Jul;18(7):876-82. doi: 10.1016/j.joca.2010.03.014. Epub 2010 Apr 22.
7
8
Diabetes-accelerated experimental osteoarthritis is prevented by autophagy activation.自噬激活可预防糖尿病加速的实验性骨关节炎。
Osteoarthritis Cartilage. 2016 Dec;24(12):2116-2125. doi: 10.1016/j.joca.2016.06.019. Epub 2016 Jul 5.
9
Compositional Variation and Functional Mechanism of Exosomes in the Articular Microenvironment in Knee Osteoarthritis.关节微环境中骨关节炎膝关节细胞外囊泡的组成变化及其功能机制。
Cell Transplant. 2020 Jan-Dec;29:963689720968495. doi: 10.1177/0963689720968495.
10
Intraarticular Ligament Degeneration Is Interrelated with Cartilage and Bone Destruction in Osteoarthritis.关节内韧带退变与骨关节炎中的软骨和骨破坏有关。
Cells. 2019 Aug 27;8(9):990. doi: 10.3390/cells8090990.
引用本文的文献
1
Metformin as adjuvant therapy in obese knee osteoarthritis patients.二甲双胍作为肥胖膝骨关节炎患者的辅助治疗。
Inflammopharmacology. 2024 Aug;32(4):2349-2359. doi: 10.1007/s10787-024-01495-y. Epub 2024 Jun 13.
2
Development of a New Benzofuran-Pyrazole-Pyridine-Based Molecule for the Management of Osteoarthritis.新型苯并呋喃-吡唑-吡啶类分子用于骨关节炎治疗的开发。
Molecules. 2023 Sep 27;28(19):6814. doi: 10.3390/molecules28196814.
3
Obesity-Related Knee Osteoarthritis-Current Concepts.肥胖相关性膝骨关节炎——当前概念
Life (Basel). 2023 Jul 28;13(8):1650. doi: 10.3390/life13081650.
4
New Method for Reduced-Number IMU Estimation in Observing Human Joint Motion.用于观测人体关节运动的低数量 IMU 估计的新方法。
Sensors (Basel). 2023 Jun 19;23(12):5712. doi: 10.3390/s23125712.
本文引用的文献
1
Relative Efficacy and Safety of Anti-Inflammatory Biologic Agents for Osteoarthritis: A Conventional and Network Meta-Analysis.抗炎生物制剂治疗骨关节炎的相对疗效和安全性：一项传统和网状Meta分析
J Clin Med. 2022 Jul 7;11(14):3958. doi: 10.3390/jcm11143958.
2
Homologous Use of Allogeneic Umbilical Cord Tissue to Reduce Knee Pain and Improve Knee Function.同种异体脐带组织的同源性应用以减轻膝关节疼痛并改善膝关节功能。
Life (Basel). 2022 Feb 9;12(2):260. doi: 10.3390/life12020260.
3
The effects of different antihypertensive drugs on pain and joint space width of knee osteoarthritis - A comparative study with data from Osteoarthritis Initiative.不同降压药物对膝骨关节炎疼痛和关节间隙宽度的影响——来自 Osteoarthritis Initiative 的数据比较研究。
J Clin Hypertens (Greenwich). 2021 Nov;23(11):2009-2015. doi: 10.1111/jch.14362. Epub 2021 Oct 17.
4
Serum Leptin and Resistin Levels in Knee Osteoarthritis-Clinical and Radiologic Links: Towards Precise Definition of Metabolic Type Knee Osteoarthritis.膝骨关节炎患者血清瘦素和抵抗素水平——临床与影像学关联：迈向代谢型膝骨关节炎的精准定义
Biomedicines. 2021 Aug 15;9(8):1019. doi: 10.3390/biomedicines9081019.
5
Disease-Modifying Potential of Metformin and Alendronate in an Experimental Mouse Model of Osteoarthritis.二甲双胍和阿仑膦酸盐在骨关节炎实验小鼠模型中的疾病修饰潜力
Biomedicines. 2021 Aug 15;9(8):1017. doi: 10.3390/biomedicines9081017.
6
Mesenchymal Stem Cells: Current Concepts in the Management of Inflammation in Osteoarthritis.间充质干细胞：骨关节炎炎症管理的当前概念
Biomedicines. 2021 Jul 7;9(7):785. doi: 10.3390/biomedicines9070785.
7
The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date.骨关节炎（DMOAD）治疗药物的研发：现有证据。
Drug Des Devel Ther. 2021 Jul 6;15:2921-2945. doi: 10.2147/DDDT.S295224. eCollection 2021.
8
Bisphosphonates as disease-modifying drugs in osteoarthritis preclinical studies: a systematic review from 2000 to 2020.双膦酸盐类药物作为骨关节炎疾病修饰药物的临床前研究：2000年至2020年的系统评价
Arthritis Res Ther. 2021 Feb 22;23(1):60. doi: 10.1186/s13075-021-02446-6.
9
A Phase 2b randomized trial of lorecivivint, a novel intra-articular CLK2/DYRK1A inhibitor and Wnt pathway modulator for knee osteoarthritis.一项 lorecivivint（一种新型关节内 CLK2/DYRK1A 抑制剂和 Wnt 通路调节剂）治疗膝骨关节炎的 2b 期随机临床试验。
Osteoarthritis Cartilage. 2021 May;29(5):654-666. doi: 10.1016/j.joca.2021.02.004. Epub 2021 Feb 12.
10
Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis: The FORWARD Randomized Clinical Trial.Sprifermin 关节内注射与安慰剂对骨关节炎患者股胫关节软骨厚度的影响：前瞻性随机临床试验。
JAMA. 2019 Oct 8;322(14):1360-1370. doi: 10.1001/jama.2019.14735.
Zotero 插件